Minicircle Named One of 10 Finalists in the $101M XPRIZE Healthspan Competition
Minicircle, a pioneering plasmid gene therapy company devoted to leading the future of public health, today announced its selection as one of the Top 10 Finalists in the global XPRIZE Healthspan competition. The seven‑year, $101 million challenge is the largest incentive prize ever launched in the field of aging, designed to catalyze breakthroughs that restore muscle, cognitive, and immune function in adults aged 50–80, delivering measurable rejuvenation equivalent to turning back the clock 10 to 20 years.
